Valo Health
PrivateLast Round
Strategic
Jan 8, 2025
Est. Valuation
$2.8B
Total Funding Raised
$1.02B
Company Overview
Valo Health is a biotechnology company that leverages human-centric data and artificial intelligence through its Opal Computational Platform to streamline and accelerate the drug discovery and development process.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valo Health Comparables
Compare Valo Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insitro | 91% | |
| Insilico Medicine | 87% | |
| Terray Therapeutics | 83% |
Valo Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 8, 2025 | ||||
| Series C | Oct 28, 2022 | ||||
| M&A | Nov 15, 2021 | ||||
| SPAC Merger / PIPE | Jun 9, 2021 | ||||
| Series B | Mar 9, 2021 | ||||
Series B | Jan 11, 2021 |
Key People
Founding team and executive leadership
Valo Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hercules Capital | Debt |
| Global Founders Capital | Series C |
| Khosla Ventures | SPAC Merger / PIPE, M&A, Series B |
| MissionBlue Capital Partners | Series B |
| Longevity Vision Fund | SPAC Merger / PIPE, Series C, M&A |
| Public Sector Pension Investment Board | SPAC Merger / PIPE, Series A, M&A, Series B |
| CAZ Investments | SPAC Merger / PIPE, M&A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2026
Karin Conde-Knape appointed as the new Chief Scientific Officer.
- Dec 2, 2025
Rita Kale appointed as Chief Financial Officer.
Valo Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Valo Health's valuation, stock price, and market status.
Is ValoHealth a public or private company?
ValoHealth is a private company.
What is the current stock price of ValoHealth?
ValoHealth is a private company with no public stock price. No recent secondary market data is available.
How much is ValoHealth worth (valuation)?
ValoHealth's valuation is estimated at $2.8B based on funding round data.
Can I buy ValoHealth stock?
ValoHealth shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ValoHealth's last funding round?
ValoHealth's most recent funding round was SPAC Merger on November 15, 2021.
Who are the main investors in ValoHealth?
Key investors in ValoHealth include Public Sector Pension Investment Board, Koch Disruptive Technologies, Flagship Pioneering, Koch Disruptive Technologies.
Will ValoHealth IPO soon?
No public IPO plans have been announced for ValoHealth.
How can I track ValoHealth secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ValoHealth's secondary market activity and sign up for updates.